Canavan Disease Clinical Trial
Official title:
A Combination Retrospective Medical History and Prospective Observational Study of Patients With Canavan Disease for Assessment of Natural History of Canavan Disease
This study uses medical records that allow retrospective data extraction of critical milestone and motor function data. In addition, prospective assessments collect data relevant to the natural history of Canavan disease in children.
The CANinform natural history study is the first multinational effort to rigorously gather both retrospective and prospective data from this patient population. Data collection includes extraction of retrospective data from medical records of living and deceased patients, and collection of prospective, longitudinal data from living patients and their parent(s)/caregiver(s). Motor function assessments are performed remotely in the home via video or in the clinic by qualified study team members. Families will be invited to attend clinic visits and/or will be followed remotely by the clinical site for approximately 3 years. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04998396 -
A Study of AAV9 Gene Therapy in Participants With Canavan Disease
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00657748 -
Lithium and Acetate for Canavan Disease
|
Phase 2 | |
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Completed |
NCT02851563 -
A Natural History Study of Canavan Disease
|
||
Recruiting |
NCT00724802 -
Oral Glyceryl Triacetate (GTA) in Newborns With Canavan
|
N/A | |
Completed |
NCT01999257 -
Efficacy Study of an Online Educational Module Before Carrier Genetic Screening in Persons of Ashkenazi Jewish Descent.
|
N/A | |
Active, not recruiting |
NCT02699190 -
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
|
||
Recruiting |
NCT03047369 -
The Myelin Disorders Biorepository Project
|
||
Recruiting |
NCT04833907 -
rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease
|
Phase 1/Phase 2 | |
No longer available |
NCT05317780 -
Canavan-Single Patient IND
|